Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page
Your Search Results: 13 Clinics in the Monroe Clinic health system


The results below represent the care of 2,141 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
COLONY BRANDS IOWA

The number of patients or providers is too small for
purposes of reliably reporting performance
COLONY BRANDS MONROE

The number of patients or providers is too small for
purposes of reliably reporting performance
MONROE CLINIC ALBANY

The number of patients or providers is too small for
purposes of reliably reporting performance
MONROE CLINIC BLANCHARDVILLE

The number of patients or providers is too small for
purposes of reliably reporting performance
MONROE CLINIC BRODHEAD
N=389
87.40 %
View Historical Data
MONROE CLINIC DURAND

The number of patients or providers is too small for
purposes of reliably reporting performance
MONROE CLINIC FREEPORT
N=400
78.25 %
View Historical Data
MONROE CLINIC HIGHLAND WOMENS CARE

The number of patients or providers is too small for
purposes of reliably reporting performance
MONROE CLINIC LENA
N=171
94.74 %
View Historical Data
MONROE CLINIC MONROE
N=1040
87.60 %
View Historical Data
MONROE CLINIC NEW GLARUS
N=141
75.18 %
View Historical Data
MONROE CLINIC URGENT CARE

The number of patients or providers is too small for
purposes of reliably reporting performance
THE MONROE CLINIC HOSPITAL

The number of patients or providers is too small for
purposes of reliably reporting performance

In November 2013, The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines released updated guidance for the treatment of blood cholesterol. The new recommendations remove treatment targets for LDL-C for the primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and recommend high or moderate intensity statin therapy based on patient risk factors. Four major stain benefit groups were identified and diabetics age 40 to 75 years, regardless of LDL-C level and without clinical ASCVD are one of the identified groups.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.